A detailed history of Srs Capital Advisors, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 15,479 shares of JNJ stock, worth $2.4 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
15,479
Previous 15,621 0.91%
Holding current value
$2.4 Million
Previous $2.28 Million 9.86%
% of portfolio
0.24%
Previous 0.23%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$145.48 - $167.38 $20,658 - $23,767
-142 Reduced 0.91%
15,479 $2.51 Million
Q2 2024

Aug 06, 2024

BUY
$144.38 - $157.78 $51,399 - $56,169
356 Added 2.33%
15,621 $2.28 Million
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $276,136 - $289,514
-1,779 Reduced 10.44%
15,265 $2.41 Million
Q4 2023

Feb 06, 2024

SELL
$145.6 - $158.88 $35,817 - $39,084
-246 Reduced 1.42%
17,044 $2.67 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $8,877 - $9,945
-57 Reduced 0.33%
17,290 $2.69 Million
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $11,267 - $12,126
73 Added 0.42%
17,347 $2.87 Million
Q1 2023

May 16, 2023

SELL
$151.05 - $180.26 $11,177 - $13,339
-74 Reduced 0.43%
17,274 $2.68 Million
Q4 2022

Feb 24, 2023

SELL
$160.2 - $179.79 $16,660 - $18,698
-104 Reduced 0.6%
17,348 $3.06 Million
Q3 2022

Nov 03, 2022

BUY
$161.33 - $179.52 $157,619 - $175,391
977 Added 5.93%
17,452 $2.85 Million
Q2 2022

Aug 22, 2022

BUY
$168.19 - $186.01 $89,813 - $99,329
534 Added 3.35%
16,475 $2.93 Million
Q1 2022

May 12, 2022

BUY
$158.14 - $179.59 $1,581 - $1,795
10 Added 0.06%
15,941 $2.83 Million
Q4 2021

Feb 08, 2022

BUY
$155.93 - $173.01 $6,860 - $7,612
44 Added 0.28%
15,931 $2.73 Million
Q3 2021

Nov 05, 2021

BUY
$161.5 - $179.47 $38,275 - $42,534
237 Added 1.51%
15,887 $2.57 Million
Q2 2021

Aug 02, 2021

BUY
$159.48 - $171.07 $21,370 - $22,923
134 Added 0.86%
15,650 $2.58 Million
Q3 2020

Nov 12, 2020

SELL
$140.38 - $153.83 $94,756 - $103,835
-675 Reduced 4.17%
15,516 $2.31 Million
Q2 2020

Aug 06, 2020

SELL
$128.81 - $155.51 $98,926 - $119,431
-768 Reduced 4.53%
16,191 $2.28 Million
Q1 2020

May 13, 2020

SELL
$111.14 - $153.99 $61,349 - $85,002
-552 Reduced 3.15%
16,959 $2.22 Million
Q4 2019

Feb 07, 2020

BUY
$127.5 - $146.44 $7,522 - $8,639
59 Added 0.34%
17,511 $2.55 Million
Q3 2019

Nov 01, 2019

BUY
$126.95 - $142.14 $10,029 - $11,229
79 Added 0.45%
17,452 $2.26 Million
Q2 2019

Aug 08, 2019

SELL
$131.15 - $144.24 $181,511 - $199,628
-1,384 Reduced 7.38%
17,373 $2.42 Million
Q4 2018

Feb 06, 2019

BUY
$122.84 - $147.84 $196,052 - $235,952
1,596 Added 9.3%
18,757 $2.42 Million
Q3 2018

Nov 06, 2018

SELL
$121.58 - $142.88 $918,050 - $1.08 Million
-7,551 Reduced 30.56%
17,161 $2.37 Million
Q2 2018

Aug 21, 2018

BUY
$119.4 - $131.76 $1.23 Million - $1.35 Million
10,272 Added 71.14%
24,712 $3 Million
Q1 2018

May 14, 2018

SELL
$125.1 - $148.14 $143,364 - $169,768
-1,146 Reduced 7.35%
14,440 $1.85 Million
Q4 2017

Feb 15, 2018

BUY
$131.22 - $143.62 $1 Million - $1.09 Million
7,623 Added 95.73%
15,586 $2.18 Million
Q3 2017

Nov 15, 2017

BUY
$129.47 - $135.38 $1.03 Million - $1.08 Million
7,963
7,963 $1.04 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.